Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Harper Meds vs June Health

Harper Meds
Graded #82

Higher grade

vs+9.200000000000003
June Health
Graded #261

Lower grade

The verdict

Harper Meds takes it — 72.2/100 to 63/100.

Harper Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. DTC telehealth weight-loss program (Nexus Health Solutions LLC) offering flat-rate compounded semaglutide and tirzepatide, with the consultation, prescription, medication, and shipping bundled into one…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueHarper Meds +25
86
61
Dose & formulationJune Health +3
72
75
Clinical oversightHarper Meds +15
74
59
Labs & monitoringHarper Meds +2
53
51
FulfillmentHarper Meds +2
76
74
Contract termsEven
55
55
Harper Meds · left barJune Health · right bar

The numbers

MetricHarper MedsJune Health
WeighScore72.2/10063/100
GradeCC
Scorecard rank#82#261
Semaglutide$149/mo$179/mo (starting dose, compounded)
Tirzepatide$196/mo$179/mo (starting dose, compounded)
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyYes
Harper Meds

Graded #82 · C

Strengths

  • Flat pricing — same cost at every dose, no escalation as you titrate up
  • All-inclusive: doctor consultation, prescription, medication, and free shipping in one price
  • LegitScript-certified; prescriptions reviewed by US-licensed M.D.s
  • Offers both compounded semaglutide ($149/mo) and tirzepatide ($196/mo)

Where it loses points

  • Membership fee is non-refundable once paid
  • Partner pharmacy is not publicly named
  • State availability not published (limited to 'certain states')
June Health

Graded #261 · C

Strengths

  • Offers both injectable and oral compounded semaglutide and tirzepatide
  • Semaglutide starts at $179/mo (injectable) or $187/mo (tablets) — tirzepatide from $179/mo (injectable)
  • Full per-dose price list published on-site with no signup required to view it
  • Provider consult ('licensed clinician evaluation') is bundled into the displayed price
  • Free discreet shipping advertised with 2-3 day delivery

Where it loses points

  • No accessible Terms of Service or Privacy Policy — footer links go nowhere and standard URL guesses 404
  • No LegitScript seal or other pharmacy-verification badge found anywhere on the site
  • Legal entity, prescribing medical group, and compounding pharmacy partner are not named
  • Domain was registered in May 2026 — a brand-new storefront with no independent reviews found
  • Also sells 'MR-3' (retatrutide), a GLP-1/GIP/glucagon agonist with no FDA approval for any use

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard